Health Prob Civil.
1. Chandrasekaran P. The role of obesity in type 2 diabetes mellitus – an overview. Mol Sci. 2024; 25: 1-21. https://doi.org/10.3390/ijms25031882
2.
Murtaza G, Riaz S, Zafar M, Raza MA, Kaleem I, Imran H, et al. Examining the growing challenge: prevalence of diabetes in young adults (Review). Med Int. 2025; 5(1): 1-8. https://doi.org/10.3892/mi.2024.201
3.
Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications – risks and mitigation. EPMA J. 2023; 14: 21-42. https://doi.org/10.1007/s13167-023-00314-8
4.
Amsalu H, Hailu M, Asefa A, Ayenew M. The effect of lifestyle factors on chronic complications of diabetes at public health hospitals in Southwest Ethiopia. Sci Rep. 2024; 14: 1-9. https://doi.org/10.1038/s41598-024-69527-9
5.
Zhu XY, Shi MQ, Jiang ZM, Li X, Tian JW, Su FF. Global, regional, and national burden of cardiovascular diseases attributable to metabolic risks across all age groups from 1990 to 2021: an analysis of the 2021 global burden of disease study data. BMC Public Health. 2025; 25: 1-21. https://doi.org/10.1186/s12889-025-22702-7
6.
Marassi M, Cignarella A, Russo GT, Nollino L, Strazzabosco M, Marzullo P, et al. Sex differences in the weight response to GLP-1RA in people with type 2 diabetes. A long-term longitudinal real-world study. Int J Mol Sci. 2025; 219(April): 1-9. https://doi.org/10.1016/j.phrs.2025.107866
7.
Ciarambino T, Crispino P, Leto G, Mastrolorenzo E, Para O, Giordano M. Influence of gender in diabetes mellitus and its complication. Int J Mol Sci Rev. 2022; 23(16): 1-13. https://doi.org/10.3390/ijms23168850
8.
Jaza H, Salh H, Aziz TA, Ahmed ZA. Association between albuminuria, glycated hemoglobin with comorbidities in type 2 diabetes patients: experience in Sulaimani City, Iraq. Al-Rafidain J Med Sci. 2024; 6(1): 1-8. https://doi.org/10.54133/ajms.v6i1.380
9.
Alrubaiee GG. Prevalence of chronic diabetic complications and associated risk factors among follow-up diabetic patients: estimates from a referral national diabetes center in Yemen. BMC Endocr Disord. 2025 ;25(68): 1-11. https://doi.org/10.1186/s12902-025-01893-5
10.
Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, et al. Cardiovascular complications of diabetes : from microvascular to macrovascular pathways. Cureus. 2023; 15(9): 1-14. https://doi.org/10.7759/cureus.45835
11.
Caycho-Rodríguez T, Vilca LV, Corrales-Reyes IE, Hernández-García F, Pupo Pérez A, González Quintana P, et al. COVID-19 contagion concern scale (PRE-COVID-19 ): Validation in Cuban patients with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021; 15(5): 102245. https://doi.org/10.1016/j.dsx.2021.102245
12.
Yedjou CG, Sims JN, Njiki S, Chitoh AM, Cherkos AS, Tchounwou PB. Health and racial disparities in diabetes mellitus prevalence, management, policies, and outcomes in the United States. PMC. 2024; 8(3): 1-27. https://doi.org/10.29011/2577-2228.100460
13.
Care D, Suppl SS, Brown FM, Bruemmer D, Collins BS, Cusi K, et al. Introduction and methodology: standards of care in diabetes – 2023. Diabetes Care. 2023; 46(1): 1-4.
14.
Rob A, Hoque A, Asaduzzaman M, Ali M, Khatoon A, Thomas D, et al. The global challenges of type 2 diabetes. Bangladesh J Med. 2025; 36(2): 92-98. https://doi.org/10.3329/bjm.v36i2.78406
15.
Abusaib M, Ahmed M, Nwayyir HA, Alidrisi HA, Al-Abbood M, Al-Bayati A, et al. Iraqi experts consensus on the management of type 2 diabetes/prediabetes in adults. Clin Med Insights Endocrinol Diabetes. 2020; 13: 1-11. https://doi.org/10.1177/1179551420942232
16.
Shafiee G, Gharibzadeh S, Panahi N, Razi F, Arzaghi SM, Haghpanah V, et al. Management goal achievements of diabetes care in Iran: study profile and main findings of DiaCare survey. J Diabetes Metab Disord. 2023; 22(1): 355-366. https://doi.org/10.1007/s40200-022-01149-2
17.
Ali J, Muhammad S, Haider S, Ali SM, Haider T, Anwar A, et al. Overall clinical features of type 2 diabetes mellitus with respect to gender. J Diabetes Metab Disord. 2023; 15(3). https://doi.org/10.7759/cureus.35771
18.
Alidrisi HA, Al-ibadi AA, Al-saidi JS, Alsawad MA, Jameel AA, Al-shati AW. Comparative analysis of glycemic and lipid profiles in newly diagnosed males and females with type 2 diabetes mellitus. Cureus. 2023; 15(12): 6-13. https://doi.org/10.7759/cureus.50101
19.
Wondm SA, Zeleke TK, Dagnew SB, Moges A, Tarekegn GY, Belachew EA. Association between self-care activities and glycemic control among patients with type 2 diabetes mellitus in Northwest Ethiopia general hospitals: a multicenter cross-sectional study. Sci Rep. 2024; 14(1): 1-15. https://doi.org/10.1038/s41598-024-72981-0
20.
Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia. 2023; 66: 986-1002. https://doi.org/10.1007/s00125-023-05891-x
21.
Al-Rubaye AAH. Risk factors of hypertension in Basra governorate. Intern ional J Biosci Biochem. 2024; 6(1): 102-107. https://doi.org/10.33545/26646536.2024.v6.i1b.69
22.
Ülgü MM, Gülkesen KH, Akünal A, Ayvalı MO, Zayim N, Birinci Ş, et al. Characteristics of diabetes mellitus patients in Turkey: an analysis of national electronic health records. Turkish J Med Sci. 2023; 53(1): 316-322. https://doi.org/10.55730/1300-0144.5587
23.
Ruze R, Liu T, Zou X, Song J, Chen Y, Xu R, Yin X, et al. Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis. Front Endocrinol (Lausanne). 2023; 14: 1-23. https://doi.org/10.3389/fendo.2023.1161521
24.
Xie X, Wu C, Hao Y, Wang T. Benefits and risks of drug combination therapy for diabetes mellitus and its complications: a comprehensive review. Front Endocrinol (Lausanne). 2023; 14: 1-17. https://doi.org/10.3389/fendo.2023.1301093
25.
Kim JY, Kim NH. Initial combination therapy in type 2 diabetes. Endocrinol Metab. 2024; 39(1): 23-32. https://doi.org/10.3803/EnM.2023.1816
26.
Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) management of hyperglycemia in type 2 diabetes, 2022. Diabetes Care. 2022; 45(11): 2753-2786. https://doi.org/10.2337/dci22-0034
27.
Che M, Zhou Q, Lin W, Yang Y, Sun M, Liu X, et al. Healthy lifestyle score and glycemic control in type 2 diabetes mellitus patients: a city-wide survey in China. Healthcare. 2023; 11(14): 1-12. https://doi.org/10.3390/healthcare11142037
28.
Al-Chawishli S, Dizaye K, Azeez S. Measuring diabetic medication adherence and factors that lead to non-adherence among patients in Erbil. Cureus. 2024; 16(9): 1-20. https://doi.org/10.7759/cureus.70397
29.
Reed J, Bain S, Kanamarlapudi V, Bain S. A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives. Diabetes Metab Syndr Obes. 2021; 14: 3567-3602. https://doi.org/10.2147/DMSO.S319895
30.
Andersson E, Brådvik G, Nilsson FOL, Arpegård J, Strambi A. Prevalence of diabetes and hospitalization due to poor glycemic control in people with bladder cancer or renal cell carcinoma in Sweden. BMC Urol. 2024; 24: 1-12. https://doi.org/10.1186/s12894-024-01536-2
31.
Szablewski L. Insulin resistance: the increased risk of cancers. Curr Oncol. 2024; 31(2): 998-1027. https://doi.org/10.3390/curroncol31020075
32.
Yahaya JJ, Doya IF, Morgan ED, Ngaiza AI, Bintabara D. Poor glycemic control and associated factors among patients with type 2 diabetes mellitus: a cross‑sectional study. Sci Rep. 2023; 13(1): 1-10. https://doi.org/10.1038/s41598-023-36675-3
33.
Rosenfeld RM, Grega ML, Karlsen MC, Moain A, Dabrh A, Aurora RN, et al. Lifestyle interventions for treatment and remission of type 2 diabetes and prediabetes in adults: a clinical practice guideline from the American College of Lifestyle Medicine. American Journal of Lifestyle Medicine. 2025; 19(2 suppl): 10S-131S. https://doi.org/10.1177/15598276251325488
Copyright: © 2025 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
